EGFR lung cancer

ASCO: Merck's Keytruda trips in EGFR lung cancer as Roche's Tecentriq fails in kidney cancer
Fierce Pharma
Tue, 06/6/23 - 04:19 pm
ASCO 2023
Merck
Keytruda
EGFR lung cancer
Roche
Tecentriq
kidney cancer
Lilly touts Cyramza lung cancer data, as AZ’s Tagrisso grows even more powerful
Fierce Pharma
Mon, 10/7/19 - 12:18 pm
EGFR lung cancer
lung cancer
Eli Lilly
Cyramza
AstraZeneca
Tagrisso
ESMO: AstraZeneca eyes payer boost with Tagrisso's latest survival win
Fierce Pharma
Sun, 09/29/19 - 09:29 pm
AstraZeneca
Tagrisso
EGFR lung cancer
ESMO
Chi-Med, AstraZeneca's savolitinib helps some Tagrisso-resistant EGFR lung cancer patients
Fierce Pharma
Sun, 03/31/19 - 03:44 pm
Chi-Med
savolitinib
AstraZeneca
Tagrisso
EGFR lung cancer